4528 — ONO PHARMACEUTICAL Share News
0.000.00%
Last trade - 00:00Brief: Ono Enters Into A Drug Discovery Collaboration & Option Agreement With Shattuck Labs To Generate Bifunctional Fusion Proteins
Table: Ono Pharm -9-MTH group results (IFRS)
President Sagara To Become Chairman And CEO Effective April 1
Brief: Ono Pharmaceutical Co Ltd Announces Result Of Share Buy Back For December
Announces Result Of Share Buyback For November
Table: Ono Pharm -6-MTH group results (IFRS)
Bought Back 2.1 Million Own Shares Worth 5.9 Billion Yen In September
Brief: Ono Enters Into A Drug Discovery Collaboration Agreement With Adimab
Bought Back 7.79 Million Own Shares Worth 21.3 Billion Yen In August
Table: Ono Pharm -Q1 group results (IFRS)
Brief: Ono Pharmaceutical Settled Antibody-Related Patent Litigation With Astrazeneca, To Receive About $140 Million
To Buy Back Up To 3.89% Of Own Shares Worth 50 Billion Yen, And Retire Them
Table: Ono Pharm -2022/23 group results (IFRS)
Table: Ono Pharm -9-MTH group results (IFRS)
Equillium gains on selling option to purchase antibody drug rights
Brief: Equillium And Ono Pharmaceutical Announce Exclusive Option And Asset Purchase Agreement For Development And Commercialization Of Itolizumab
Table: Ono Pharm -6-MTH group results (IFRS)
Table: Ono Pharm -Q1 group results (IFRS)
Table: Ono Pharm -2021/22 group results (IFRS)